Patent10 Feb 2026, 04:52 pm
Kimia Biosciences Granted 20-Year Patent for Improved Luliconazole Preparation Process
AI Summary
Kimia Biosciences Limited has been granted a patent for an improved process for the preparation of Luliconazole, an antifungal active pharmaceutical ingredient (API), by The Patent Office, Government of India. The patent, valid for 20 years, strengthens the company's intellectual property portfolio and is expected to bolster its long-term business prospects in the antifungal API segment. The patent certificate was granted on 29th January 2026, with the renewal fees becoming due on the same day every year, starting from January 2024.
Key Highlights
- Kimia Biosciences has been granted a 20-year patent for an improved Luliconazole preparation process.
- The patent strengthens the company's intellectual property portfolio in the antifungal API segment.
- The patent is expected to enhance the company's long-term business prospects.
- The patent certificate was granted on 29th January 2026.
- Renewal fees for the patent become due on the same day every year, starting from January 2024.